When a healthy young athlete collapses near the end of a marathon, the shock obscures a quieter truth: catastrophic medical events in distance racing are vanishingly rare, yet when they occur, survival hinges on seconds, systems, and physiology most runners never think about.
At a Glance
- A 24-year-old runner, Rachel Apa, collapsed near mile 24 of the New York City Marathon and later died despite immediate bystander CPR, on-course medical care, defibrillation, and rapid transport.
- Organizers and police detailed a tight response timeline; her father told reporters the family attributes her death to rhabdomyolysis, a severe exertional muscle-breakdown syndrome.
- Texts to her father during the race described escalating pain before the collapse, consistent with—but not diagnostic of—exertional injury.
- Life-threatening events during long-distance races are rare; large registries place cardiac-arrest incidence around 0.5 per 100,000 participants, underscoring how unusual a fatality is at a major marathon.
What happened on the course and after
Rachel Apa collapsed late in the New York City Marathon, around the 24-mile mark on Fifth Avenue abutting Central Park—roughly two miles from the finish. According to the New York Road Runners and law enforcement accounts cited in national reporting, a bystander immediately began CPR before event medical personnel arrived, deployed a defibrillator, and arranged ambulance transport to Mount Sinai, where she was later pronounced dead. The specificity of the operational record is unusual for public reporting on a mass-participation event: outlets placed the collapse near 1:30 p.m., advanced life support on scene minutes later, and hospital transfer shortly thereafter. That timeline—collapse, on-site resuscitation, rapid evacuation—follows the doctrine that governs modern race medicine: minimize low-flow time and move decisively from sidewalk to definitive care.
In the hours leading up to the incident, Apa was texting with her father, Steve, who tracked her progress from Pennsylvania. He described messages that shifted from encouragement to brief complaints of pain—“Ow,” then “Ow ow”—around miles 18–19, followed by silence as she continued forward into Manhattan; she collapsed near mile 24. This is exactly the stretch of the course where late-race stress peaks: the climb along Fifth Avenue and the rolling terrain of Central Park generate maximal metabolic and orthopedic strain at a moment when glycogen is impaired and thermal balance is fragile.
Rhabdomyolysis: the mechanism, and why it can be lethal
Apa’s family told reporters she died from rhabdomyolysis—often shortened to “rhabdo”—a syndrome in which damaged skeletal muscle breaks down, flooding the bloodstream with intracellular contents such as myoglobin, potassium, and creatine kinase. In exertional forms, intense or prolonged effort, heat stress, dehydration, certain medications or supplements, and underlying myopathies can contribute to muscle cell membrane failure. Clinically, rhabdo is diagnosed by a characteristic laboratory profile (markedly elevated creatine kinase, myoglobinuria), symptoms (severe muscle pain, weakness, swelling), and in serious cases, complications including acute kidney injury and life-threatening arrhythmias from electrolyte derangements. In the field, the early warning signs a runner might actually notice are crude but actionable: profound muscle pain out of proportion to usual fatigue and dark, cola-colored urine after heavy exertion. Emergent care is centered on aggressive fluid resuscitation, managing electrolytes, and monitoring for renal failure and cardiac instability.
Fatal exertional rhabdomyolysis in an otherwise young adult is uncommon, but medically plausible—especially when exertion is prolonged, environmental conditions are taxing, or underlying vulnerabilities exist. The family attribution places this tragedy within that mechanistic frame. A single caveat belongs here: formal clinical confirmation hinges on hospital and medical-examiner records, which are not public in this coverage.
How rare are life-threatening events in distance races?
The epidemiology is reassuring for the millions who line up each year. Large registries of U.S. long-distance events spanning tens of millions of finishers estimate cardiac-arrest incidence on the order of 0.5 to 0.6 per 100,000 participants; deaths represent a fraction of those arrests, and risk is concentrated among men in their 40s to 50s with occult cardiac disease. A prospective registry from the Paris region, covering more than a million runners across marathons and half marathons, found approximately 3.35 life‑threatening events per 100,000 participants—a figure that includes non-cardiac etiologies such as exertional heat stroke and severe metabolic collapse. These data do not trivialize a single fatality; they contextualize it. In a field the size of New York’s, even rare risks can surface, which is why modern races are essentially pop-up medical systems with distributed defibrillators, mobile teams, and hospital pre-alert protocols.
Outcomes depend on choreography as much as on pathology. Rapid recognition bystanders, immediate CPR, early defibrillation when appropriate, and fast handoff to advanced life support are the determinants repeatedly shown to shift survival curves to the right. In organized race settings—Tokyo, Paris, Chicago, New York—AED density and trained volunteers are not window dressing; they are survival infrastructure.
What experts look for when an athlete collapses
Collapse in the late miles has a focused differential diagnosis. Cardiac causes—ventricular arrhythmias from underlying structural disease or ischemia—dominate the fatal category. But non-cardiac conditions can present abruptly: exertional heat stroke with central nervous system dysfunction, hyponatremia with cerebral edema, severe dehydration with hypovolemic collapse, and exertional rhabdomyolysis with electrolyte instability. The initial field assessment is pragmatic: airway, breathing, circulation; core temperature; mental status; point-of-care glucose; and, when indicated, early defibrillation. At the hospital, the workup broadens to electrolytes, renal function, creatine kinase, ECG, urinalysis for myoglobin, and imaging or cardiac testing as needed. That is how clinicians disentangle what looks similar on the pavement but diverges in the lab.
In Apa’s case, two facts are compatible with an exertional mechanism: the late-course timing after sustained effort and the complaint of significant pain in the musculoskeletal window. Neither detail is specific; runners with overuse injuries or cramps text similar laments. But together with a family-reported rhabdomyolysis diagnosis, they outline a medically coherent path from muscle injury to systemic collapse.
Preparedness, prevention, and what runners can control
No prevention playbook eliminates risk, but endurance athletes stack the deck with choices well before race day. Progressive training that respects volume and heat acclimatization reduces the mismatch between ambition and physiology. Avoiding nonsteroidal anti-inflammatory drugs in the peri-race period (they can impair renal perfusion), scrutinizing supplements and stimulants, and maintaining balanced sodium and fluid intake guard against renal and electrolyte pitfalls that can amplify exertional injury. On the course, the most underused tool is judgment: backing off when pain localizes, when chills or confusion intrude, or when urine turns dark after heavy exertion. Those signals are not stoicism tests; they are red flags to stop and seek care.
For organizers, the lesson is not abstraction but logistics. Dense AED coverage, roving medical teams at physiologic choke points (hills late in the course, heat-trapping urban canyons), rigorous dispatch integration, and visible signage that normalizes early help-seeking change outcomes measurably. The New York City Marathon’s response sequence—immediate bystander CPR, prompt defibrillator use, swift evacuation—tracks with best practice; the difference between tragedy and survival in these edge cases is often measured in the first three minutes.
Rachel Apa, 24, Lost After Collapse in First NYC Marathon
Rachel Apa, 24, a Pennsylvania runner raising money for Parkinson’s research, collapsed near mile 24 of the NYC Marathon and later passed away.https://t.co/khKkQ8ykmP pic.twitter.com/1eDHepS06I— QNC News (@qnc_news) November 3, 2026
Why this single case matters to a much larger community
Apa’s death is a profound personal loss to her family and to a running culture that prides itself on care for its own. It is also, unavoidably, a case study—of how rare catastrophic events emerge in crowded fields, how systems respond under pressure, and how physiology can betray even the well-prepared. The base rates remind us that marathons are safe pursuits by any reasonable metric; the mechanism of exertional rhabdomyolysis reminds us that safe does not mean risk-free. Holding both truths at once is the only honest way to run forward—eyes open, systems ready, and respect for the body’s limits at the heart of the sport.
Sources:
people.com, espn.com, pmc.ncbi.nlm.nih.gov, jamanetwork.com, jacc.org, nejm.org, pubmed.ncbi.nlm.nih.gov
